SCHEMBL25813777

SCHEMBL25813777

Cc1cc(C)cc(-c2ccc(C)cc2C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
TDP1 Q9NUW8 2/20 0.42
TP53 P04637 1/20 0.42
ESR2 Q92731 2/20 0.41
ESR1 P03372 1/20 0.41
RAPGEF4 Q8WZA2 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ACHE P22303 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL284409 0.82 ESR2 (0.47) MAPTGAATDP1TP53ESR2
SCHEMBL29038580 0.81 MAPT (0.48) MAPTGAATDP1TP53ESR2
SCHEMBL5551209 0.81 ACHE (0.48) MAPTGAATP53ESR2ESR1
SCHEMBL3043421 0.81 TDP1 (0.52) MAPTGAATDP1TP53ESR2
SCHEMBL31547677 0.81 TDP1 (0.52) MAPTGAATDP1TP53ESR2
SCHEMBL714974 0.80 ALDH1A1 (0.42) MAPTGAATDP1TP53RAPGEF4
SCHEMBL5711233 0.80 TDP1 (0.42) MAPTGAATDP1TP53ESR2
SCHEMBL18722306 0.80 ESR2 (0.45) MAPTGAATDP1TP53ESR2
SCHEMBL5597351 0.79 ACHE (0.50) MAPTGAATDP1TP53ESR2
SCHEMBL17147801 0.79 ALDH1A1 (0.41) ESR2ESR1RAPGEF4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685754-B2 Heteroleptic organic electroluminescent materials UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685754-B2 Heteroleptic organic electroluminescent materials IK, ORC3, CACNA2D2 MAPT 1207/4885GAA 3991/4885TDP1 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.